• Health Economics And Outcomes Research
    Health Economics And Outcomes Research - We support bio-pharma companies with real world evidence
    and economic modeling to maximize product access and value
We support bio-pharma companies with real world evidence
and economic modeling to maximize product access and value

Health Economics and Outcomes Research

  • SmartAnalyst utilizes deep disease and domain knowledge to design and deliver successful projects for our clients.
  • We take a holistic approach to Market Access, with the ability to combine patient, payor, and physician insights and work with our clients to develop economic evidence to demonstrate the value of their products.
  • We have developed and utilized innovative methodologies, such as dynamic disease modeling to forecast epidemiology of complex diseases.
Health Economics and Outcomes Research
The SmartAnalyst Difference:
  • Domain expertise in a variety of therapeutic areas, including complex areas such as oncology
  • Data agnostic - ability to employ leading retrospective patient level databases across the globe
  • Flexibility and focus on the client experience - a collaborative working relationship
  • Extensive track record of success with a highly skilled research team
Our capabilities in Health Economics Modeling include:
  • Longitudinal Data Analysis
  • Cost-effectiveness Analysis
  • Risk Sharing Analysis
  • Budget Impact Models
  • Comparative Effectiveness Models
Our capabilities in Health Economics Modeling
Download Recent Publications
NEWS

We recently presented at:

The 59th American Society of Hematology (ASH) Annual Meeting & Exposition, December 9-12, 2017, Atlanta, GA, USA

  • Utilization of Hypomethylating Agents and Associated Outcomes in Elderly Acute Myeloid Leukemia (AML) Patients: A Population Based Study - Maneesha Mehra, Jianming He, Ravi Potluri, Christina Loefgren

  • Duration of Treatment of Multiple Myeloma Regimens in Patients with Relapsed or Refractory Multiple Myeloma: Findings in US Clinical Practice Settings - Clara Chen, Christopher Yasenchak, Ravi Potluri, Hemanth Kanakamedala, Sandip Ranjan, Eros Papademetriou, Hitesh Bhandari, Jasdeep Mann, Catherine Davis 

  • Treatment Sequencing Patterns Observed in Patients Treated Initially with Lenalidomide/ Dexamethasone Combination as Frontline Multiple Myeloma Therapy - Clara Chen, Ravi Potluri, Hemanth Kanakamedala, Eros Papademetriou, Christopher Yasenchak, Sandip Ranjan, Hitesh Bhandari, Jasdeep Mann, Catherine Davis 

  • Comparison of Overall Survival Associated with Lenalidomide + Dexamethasone and Bortezomib + Dexamethasone among Relapsed/Refractory Multiple Myeloma Patients: A Matched Analysis of Real-world and Clinical Trial Populations -Ajay Nooka, Peter Voorhees, Shaji Kumar, Maneesha Mehra, Annette Lam, Mary Slavcev, Ravi Potluri, Anandaroop Dasgupta

  • Evaluation of Efficacy Outcomes among Relapsed/Refractory Multiple Myeloma Treated Patients in a Real-World Setting - Ajay Nooka, Peter Voorhees, Shaji Kumar, Maneesha Mehra, Annette Lam, Mary Slavcev, Jon Ukropec, Ravi Potluri, Anandaroop Dasgupta

ISPOR 20th Annual European Congress, November 4-8, 2017, at the Scottish Event Campus in Glasgow, Scotland

  • Evaluation of Resource Utilization among Infants, Young Children and Elderly Patients Diagnosed with RSV Infection in the United States - Veronique Wyffels, Maartje Smulders, Sandra Gavart, Roman Fleischhackl, Debasish Mazumder, Nikhil Gupta, Jonathan Nguyen-Van-Tam




GLOBAL HEADQUARTERS
(New York, USA)

9 East 38th Street, 8th Floor,
New York 10016
Tel.: (212) 331-0010
Fax: (212) 331-0011
Fax: (866) 256-9402

EUROPE
(London, UK)

12 Hammersmith Grove,
London, W6 7AP
Mobile: +44-(0)-752-163-8242
Mobile: +44 (0) 7903 070071

ASIA PACIFIC
(Gurgaon, INDIA)

14th Floor, Tower D, Cyber Green,
DLF City Phase-III,
Gurgaon 122002, Haryana, India
Tel.: 91-124-4313800,
91-124-4147900, 91-124-4147910-13
Fax: 91-124-4313899

Latest SMARTOncology Newsletter

click here to download

Subscribe

Latest SMARTImmunology Newsletter

click here to download